Clinical Significance: Desmethylmirtazapine is the metabolite of mirtazapine used to treat depression.
Tested in both urine and oral fluid
Drug Class
Anti-Depressants
Metabolite(s)
None
Aliases
Metabolite of Mirtazapine
Methodology
Liquid Chromatography Mass Spectrometry
Urine Recommended Volume
30mL
Oral Fluid Minimum Volume
1mL
Specimen Stability
15 days
Urine Reportable Range
50-1000
Oral Fluid Reportable Range
12-300
Urine Immunoassay Cutoff (ng/mL)
N/A
Urine Window of Detection
1-10 days
Oral Fluid Window of Detection
1-10 days
Rejection Criteria
Quantity Not Sufficient or Wrong Collection Device (Oral Fluid)
Urine Transient Contanier
Urine Clinical Drug Test Transport Cup
Oral Fluid Transient Contanier
Oral Fluid Intercept 2.0 Devices